- CYTOPOINT provided lasting control of allergic itch2
- Effective and long-lasting control of chronic diseases such as allergic dermatitis lessens pet owner anxiety by restoring a household’s normal routine1
- Significant improvement in owner quality of life* was directly correlated with reduction in a dog’s atopic itch3
The Canine Dermatitis Quality of Life (QoL) instrument measured dog QoL, dog owner QoL and treatment satisfaction.
Adverse events reported in >2% of dogs in a field safety study7‡
†Other than pruritus and alopecia, which were substantially more common in dogs receiving placebo.
‡Occurrence calculated on a per-case basis—no matter how many observations of the same abnormal health event a dog had, it contributed one observation to the occurrence calculation.
See real stories of lasting relief
He is back to being that fun-loving dog...I know that he’s going to be OK. And that peace of mind is literally priceless.”
SherryAnn Quindley, Dublin’s ownerDublin's story
To see her be pain free and not irritated...has been a profound relief for me. It's a comfort to know that those days are behind her.”
Rick Sirianni, Sophie’s ownerSophie's story
This [product] truly saved both [the owner's] and my patient's lives! I don't know what I would have done without having access to this amazing [product]. Thank you Zoetis!”
Dr Lisa Reiter, Exeland’s DVMExeland's story
Harley's owner seemed very happy at the one-month recheck. It seemed like we had taken a weight off of her shoulders in terms of having to administer medication at home.”
Dr Liz Hardesty, Harley’s DVMHarley's story
In a multicenter study at veterinary practices in the US, 68 dogs diagnosed with atopic dermatitis and pruritic at the time of enrollment were analyzed. Dogs were treated with CYTOPOINT® (at label dose) monthly for 3 treatments. Dogs entered the study on Day 0 and returned for examination on Days 30, 60 and 90. The primary variables of interest were dog quality of life, owner quality of life, treatment satisfaction and owner reported Pruritus Visual Analog Scale scores (PVAS). The primary variables were analyzed by a Generalized Linear Mixed Model (GLMM) approach for repeated measures. Comparisons of Least Square Means were performed by the two-sided Student’s t-test at 5% level of significance.
For animals. For health. For you.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2020 Zoetis Services LLC. All rights reserved.